Technical Analysis for TEVA - Teva Pharmaceutical Industries

Grade Last Price % Change Price Change
grade F 16.905 1.59% 0.27
TEVA closed up 0.79 percent on Monday, March 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical TEVA trend table...

Date Alert Name Type % Chg
Mar 18 20 DMA Resistance Bearish 1.59%
Mar 18 1,2,3 Retracement Bearish Bearish Swing Setup 1.59%
Mar 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.59%
Mar 18 Up 3 Days in a Row Strength 1.59%
Mar 18 Up 4 Days in a Row Strength 1.59%
Mar 15 1,2,3 Retracement Bearish Bearish Swing Setup 2.39%
Mar 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.39%
Mar 15 MACD Bullish Signal Line Cross Bullish 2.39%
Mar 15 Inside Day Range Contraction 2.39%
Mar 15 Up 3 Days in a Row Strength 2.39%

Older signals for TEVA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances. The company's principal branded pharmaceutical products comprise Copaxone for multiple sclerosis; Provigil and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Azilect for the treatment of Parkinson's disease; Fentora and Actiq for the treatment of pain in opioid-tolerant adult patients with cancer; Amrix for muscle spasm in acute, painful, and musculoskeletal conditions; ProAir for the treatment of bronchial spasms; Qvar for long-term control of chronic bronchial asthma; and Qnasl Nasal Aerosol for seasonal nasal and year-round nasal allergy symptoms. The company also offers Treanda for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma; Tevagrastim/Ratiograstim that stimulate the production of white blood cells; Eporatio, which stimulates the production of red blood cells; Synribo for chronic myeloid leukemia; Plan B One-Step for emergency oral contraception; ParaGard, a non hormonal intrauterine contraceptive; hormone therapies for menopause/perimenopause; Enjuvia for vasomotor symptoms associated with menopause; and therapies for infertility and urinary incontinence. In addition, it produces active pharmaceutical ingredients in the areas of respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company distributes third party products. It has collaborative agreements with Lonza Group Ltd. and OncoGenex Pharmaceuticals, Inc. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
Medicine Chemistry Cancer Pharmaceutical Pain Drugs Medication Pharmaceutical Products Multiple Sclerosis Lymphoma Asthma Parkinson's Disease Active Pharmaceutical Ingredients Leukemia Chronic Lymphocytic Leukemia Treatment Of Parkinson's Disease Obstructive Sleep Apnea Generic Pharmaceutical Products Fentanyl Muscle Spasm Party Products Urinary Incontinence Chronic Myeloid Leukemia Infertility Menopause Narcolepsy Teva Pharmaceutical Industries Treatment Of Chronic Lymphocytic Leukemia
Is TEVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 25.96
52 Week Low 14.59
Average Volume 10,245,819
200-Day Moving Average 20.9824
50-Day Moving Average 17.9422
20-Day Moving Average 16.694
10-Day Moving Average 16.176
Average True Range 0.5098
ADX 30.52
+DI 19.4634
-DI 26.5532
Chandelier Exit (Long, 3 ATRs ) 16.6106
Chandelier Exit (Short, 3 ATRs ) 17.1194
Upper Bollinger Band 17.9656
Lower Bollinger Band 15.4224
Percent B (%b) 0.48
BandWidth 15.234216
MACD Line -0.5057
MACD Signal Line -0.5766
MACD Histogram 0.0709
Fundamentals Value
Market Cap 16.9 Billion
Num Shares 1.02 Billion
EPS -6.11
Price-to-Earnings (P/E) Ratio -2.72
Price-to-Sales 0.60
Price-to-Book 0.57
PEG Ratio -0.47
Dividend 1.10
Dividend Yield 6.61%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.20
Resistance 3 (R3) 17.16 16.93 17.10
Resistance 2 (R2) 16.93 16.79 16.95 17.07
Resistance 1 (R1) 16.79 16.70 16.86 16.83 17.04
Pivot Point 16.56 16.56 16.60 16.58 16.56
Support 1 (S1) 16.42 16.42 16.49 16.46 16.24
Support 2 (S2) 16.19 16.33 16.21 16.21
Support 3 (S3) 16.05 16.19 16.18
Support 4 (S4) 16.09